Company Filing History:
1 out of 94 
1 out of 1,327 
Years Active: 2025
Title: Karen Abbott: Innovator in Cancer Research
Introduction
Karen Abbott is a notable inventor based in Little Rock, Arkansas. She has made significant contributions to the field of cancer research through her innovative work on Periostin antibodies. Her research focuses on developing antigen-binding reagents that target cancer-specific modifications on the human Periostin protein.
Latest Patents
Karen Abbott holds 1 patent for her invention titled "Periostin antibodies and methods of using the same." This patent describes the development of antigen-binding reagents and conjugates that recognize a specific glycan modification on the Periostin protein. The patent also outlines various diagnostic and therapeutic methods for treating cancers associated with the amplification of the Mgat3 gene.
Career Highlights
Throughout her career, Karen has worked with several organizations, including Bioventures, LLC and SRI International. Her work has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.
Collaborations
Karen has collaborated with Nathalie Scholler, who is also a prominent figure in the field of cancer research. Their partnership has contributed to the advancement of innovative solutions for cancer treatment.
Conclusion
Karen Abbott's work exemplifies the impact of innovation in the medical field, particularly in cancer research. Her contributions continue to pave the way for new diagnostic and therapeutic approaches.